BPG is committed to discovery and dissemination of knowledge
Featured Articles
3/20/2021 3:14:54 AM | Browse: 855 | Download: 1809
Publication Name World Journal of Hepatology
Manuscript ID 62328
Country Japan
Received
2021-01-06 02:44
Peer-Review Started
2021-01-06 02:45
First Decision by Editorial Office Director
2021-01-25 03:03
Return for Revision
2021-01-25 03:03
Revised
2021-01-31 13:24
Publication Fee Transferred
Second Decision by Editor
2021-03-08 07:05
Second Decision by Editor-in-Chief
2021-03-08 09:02
Final Decision by Editorial Office Director
2021-03-11 04:05
Articles in Press
2021-03-11 04:05
Edit the Manuscript by Language Editor
Typeset the Manuscript
2021-03-16 02:24
Publish the Manuscript Online
2021-03-20 02:13
ISSN 1948-5182 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Case Report
Article Title Conversion hepatectomy for hepatocellular carcinoma with main portal vein tumour thrombus after lenvatinib treatment: A case report
Manuscript Source Invited Manuscript
All Author List Kazuhiro Takahashi, Jaejeong Kim, Amane Takahashi, Shinji Hashimoto, Manami Doi, Kinji Furuya, Ryosuke Hashimoto, Yohei Owada, Koichi Ogawa, Yusuke Ohara, Yoshimasa Akashi, Katsuji Hisakura, Tsuyoshi Enomoto, Osamu Shimomura, Masayuki Noguchi and Tatsuya Oda
Funding Agency and Grant Number
Corresponding Author Kazuhiro Takahashi, MD, PhD, Surgeon, Department of Gastrointestinal and Hepatobiliary Pancreatic Surgery, University of Tsukuba, 1-1-1 Tennoudai, Tsukuba 3058575, Ibaraki, Japan. kazu1123@md.tsukuba.ac.jp
Key Words Hepatocellular carcinoma; Lenvatinib; Portal vein tumour thrombus; Conversion hepatectomy; Case report
Core Tip Patients with hepatocellular carcinoma (HCC) with portal vein tumour thrombus demonstrate an aggressive disease course, decreased liver function reserve, and higher recurrence rates after treatment. Clinical practice guidelines recommend systemic therapy as the first-line option for HCC with portal invasion. However, to achieve longer survival in these patients, the treatment strategy should be concluded with removal of the tumour. We report the first case of HCC with main portal vein tumour thrombus, in which radical conversion hepatectomy was successfully performed after lenvatinib treatment. Lenvatinib has several strengths that validate its use for targeting conversion hepatectomy for unresectable HCC.
Publish Date 2021-03-20 02:13
Citation Takahashi K, Kim J, Takahashi A, Hashimoto S, Doi M, Furuya K, Hashimoto R, Owada Y, Ogawa K, Ohara Y, Akashi Y, Hisakura K, Enomoto T, Shimomura O, Noguchi M, Oda T. Conversion hepatectomy for hepatocellular carcinoma with main portal vein tumour thrombus after lenvatinib treatment: A case report. World J Hepatol 2021; 13(3): 384-392
URL https://www.wjgnet.com/1948-5182/full/v13/i3/384.htm
DOI https://dx.doi.org/10.4254/wjh.v13.i3.384
Full Article (PDF) WJH-13-384.pdf
Full Article (Word) WJH-13-384.docx